Exploring the therapeutic potential of atorvastatin against Gram-positive and Gram-negative bacteria: In-silico, In-vitro and In- vivo evidence.
The incidences of opportunistic bacterial infections have increased from the past two decades or threaten to increase in the near future. Inspite of the availability of various classes of antibiotics, bacterial infections are not handled properly.Thus, in the present study, we have repurposed atorvastatin against various types of bacterial strains by using in-silico, in-vitro, and in-vivo studies. Further, preliminary safety study was conducted using MTT assay. In-silico study results have revealed that atorvastatin hasgood interaction with various targets of bacterial cell as that of reference ligand. However, under in-vitro conditions, we have foundthat atorvastatin was effective at higher concentration(>128 μg/ml) against various bacterial strains. Thus, further, atorvastatin was tested in combination with standard antibiotics and has shown synergistic effect. The MTT assay results have revealed non-cytotoxic activity of atorvastatin. In conclusion, atorvastatin in combination with standard drugs could be developed as an antibacterial agent.